Building AI Models of Human Cells - Tahoe Therapeutics on Databricks

Explore how Tahoe Therapeutics leverages Databricks to revolutionize drug discovery through AI-powered cellular modeling in this 20-minute conference talk. Learn about the company's groundbreaking approach to generating gigascale single-cell data that maps drug interactions with cancer patient cells, enabling the development of more effective therapeutics. Discover the technical implementation behind the Tahoe-100M atlas, the world's largest dataset of drug responses profiling 100 million cells across 60,000 conditions, and understand how Databricks processes this massive dataset to power AI models that predict drug efficacy and resistance at the cellular level. Gain insights into scalable, data-driven drug discovery methodologies from Nima Alidoust, Co-Founder and CEO of Tahoe Therapeutics, whose company was recognized as the Grand Prize Winner of the Databricks Generative AI Startup Challenge and represents a new standard in pharmaceutical research technology.